Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2023 Earnings Call Transcript August 2, 2023
Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.24, expectations were $0.15.
Operator: Good day. And welcome to the Corcept Therapeutics Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Atabak Mokari. CFO. Please go ahead.
Atabak Mokari: Hello,...
